On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

June 30, 2016

Study Completion Date

December 15, 2016

Conditions
HIV Infection
Interventions
DRUG

Truvada

2 tablets of truvada within 24 hours before first sexual relations, then 1 tablet of Truvada during the period of sexual activity including the last sexual intercourse, finally, a last dose of 1 tablet of Truvada approximately 24 hours later

DRUG

Placebo

2 tablets of placebo within 24 hours before first sexual relations, then 1 tablet of placebo every 24 hours during the period of sexual activity including the last sexual intercourse, finally, a last dose of 1 tablet of placebo approximatively 24 hours later

Trial Locations (7)

75

Hôpital Tenon, Paris

44093

CHU Hôtel Dieu, Nantes

59208

Hôpital Gustave Dron, Tourcoing

75475

Hôpital Saint-Louis, Paris

Unknown

CHUM - Hôpital Hôtel Dieu, Montreal

Hôpital de La Croix Rousse, Lyon

06202

Hôpital de l'Archet, Nice

All Listed Sponsors
lead

ANRS, Emerging Infectious Diseases

OTHER_GOV

NCT01473472 - On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men | Biotech Hunter | Biotech Hunter